Planning & Evaluation

规划

• 批准号: 8933472
• 负责人: CRAIG B THOMPSON
• 金额: $ 8.89万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-01-01 至 2018-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8933472
• 关键词: Advisory Committees; Area; Cancer Biology; Cancer Center Support Grant; Clinical; Clinical Investigator; Clinical Research; Communities; Comprehensive Cancer Center; Core Facility; Counseling; Development; Disease; Evaluation; Evaluation Research; Experimental Pathology; Faculty; Fostering; Image; Immigrant; Instruction; Laboratories; Memorial Sloan-Kettering Cancer Center; Mission; Molecular Structure; Outcome; Policies; Population Research; Prevention program; Process; Radiation; Recommendation; Recruitment Activity; Research; Research Infrastructure; Resource Development; Risk; Science; Students; Therapeutic; Training; Training Programs; Transplantation Immunology; cancer health disparity; investigator training; meetings; member; programs; stem cell biology; survivorship

MSKCC relies on the counsel of outside advisors, represented by its Board of Scientific Consultants (BSC), the guidance of its Board of Overseers and Managers, as well as many internal planning processes to support the planning and evaluation of the research programs and core facilities at the Center. MSKCC has used the guidance it has received to develop and execute its initiatives for research and clinical expansion. During the past five years, the BSC has reviewed the research in many areas, including the Developmental and Stem Cell Biology Program, the Molecular Structure Program, the Prevention, Control and Population Research Program (now the Survivorship, Outcomes, and Risk Program), along with its efforts in Immigrant Health and Cancer Disparities, the Immunology and Transplantation Program, the Imaging and Radiation Sciences Program, the Cancer Biology and Experimental Pathology Program, Experimental Therapeutics, and disease-specific components of the Clinical Research Program. The BSC has also reviewed some of the newly recruited junior investigators and the training programs that bring outstanding students to train in MSKCC's laboratories. In addition to the BSC, the senior leaders receive strategic counsel from the MSKCC Board of Overseers and Managers to provide both community and financial stewardship as well as tactical advice on Center policies. A Task Force was also created to internally evaluate the Cores' infrastructure, and several improvements have been enacted. Through input from program members and the Associate Directors, further collaborative research centers that foster interactions between laboratory and clinical investigators have also been established. The recommendations made by the BSC and other planning groups have led to program reorganizations, new faculty recruitments, shared resource development, and facility expansions.

MSKCC依靠以其科学顾问委员会(BSC)为代表的外部顾问的咨询， 监督和管理委员会以及许多内部规划程序的指导，以 支持中心研究项目和核心设施的规划和评估。MSKCC有 使用它收到的指导来制定和执行其研究和临床扩展的倡议。 在过去的五年中，BSC对许多领域的研究进行了审查，包括发展性 和干细胞生物学计划、分子结构计划、预防、控制和人口 研究计划(现在的生存、结果和风险计划)及其在移民方面的努力 健康和癌症差异，免疫学和移植计划，成像和辐射 科学计划，癌症生物学和实验病理学计划，实验治疗学， 以及临床研究计划中针对疾病的部分。平衡计分卡还审查了一些 新招聘的初级调查员和吸引优秀学生来港培训的培训计划 MSKCC的实验室。除BSC外，高级领导人还接受MSKCC的战略咨询 监督和管理委员会，以提供社区和财务管理以及战术 关于中心政策的建议。还成立了一个工作队，对核心的基础设施进行内部评估， 并颁布了几项改进措施。通过计划成员和合作伙伴的投入 主任，进一步合作研究中心，促进实验室和临床之间的互动 调查人员也已成立。平衡计分卡提出的建议和其他规划 小组导致了项目重组、新的教师招聘、共享资源开发，以及 设施扩建。